F
220100
vs
K
KOSPI 200
Over the past 12 months, FutureChem Co Ltd has underperformed KOSPI 200, delivering a return of -53% compared to KOSPI 200's +148% growth.
Stocks Performance
220100 vs KOSPI 200
Performance Gap
220100 vs KOSPI 200
Performance By Year
220100 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
FutureChem Co Ltd
Glance View
FutureChem Co., Ltd. makes radiopharmaceuticals, which are special medicines used in nuclear medicine for diagnosing and treating disease, especially in cancer care. It develops, manufactures, and sells these products to hospitals, clinics, and medical distributors that use them in imaging tests and therapy. The company earns money mainly by selling its own branded nuclear medicine products and related pharmaceutical items. In this business, the customer is usually a hospital or specialist medical center rather than a regular retail pharmacy, so FutureChem sits in a niche part of the healthcare supply chain. What makes the business different is that radiopharmaceuticals are harder to make and deliver than ordinary drugs because they often have short usable lives and must be handled carefully. That gives FutureChem a role as a specialized supplier to medical providers that need reliable access to these high-value diagnostic and treatment products.
